Public Company News

Longsys to Unveil "Edge AI Storage Fusion" at FMS 2026, Showcasing In-Depth Innovation in Edge AI Storage

SAN JOSE, Calif., July 28, 2026 /PRNewswire/ -- FMS 2026 kicks off in California, USA, August 4–6, 2026. Longsys (301308.SZ) will attend under the theme "Edge AI Storage Fusion," showcasing its deep innovation in edge AI storage. Comprehens...

2026-07-28 07:00 5627

Quantinuum to Report Second Quarter Financial Results on August 11, 2026

BROOMFIELD, Colo., July 28, 2026 /PRNewswire/ -- Quantinuum Inc. (Nasdaq: QNT) ("Quantinuum") today announced it will release its financial results for the second quarter (ending on June 30, 2026) after market close on August 11, 2026. Quantinuum will host a conference call at 5:00 PM Eastern tim...

2026-07-28 05:00 3306

CJ 4DPLEX AND HOYTS CINEMAS CONFIRM EXPANSION OF SCREENX WITH 12 NEW LOCATIONS ACROSS AUSTRALIA AND NEW ZEALAND

SYDNEY, July 28, 2026 /PRNewswire/ -- HOYTS Cinemas has announced a major expansion of its partnership with CJ 4DPLEX, adding 12 new SCREENX auditoriums to its network across Australia and New Zealand. The first will open at HOYTS Broadway in time for the release of Spider-Man: Brand New Day, the...

2026-07-28 04:57 3974

DXC Names Holly Grant President of LabX, Expanding the Unit's Role as a Major AI Growth Engine

* Holly Grant named President, AI Innovation and Strategy & LabX, expanding her leadership across DXC's AI-native product incubation work and AI Platforms Engine * Expanded LabX brings together DXC's expertise across leading AI platforms to design, build and deploy practical AI solutions at s...

2026-07-28 04:22 6004

2026 Sands Shopping Carnival Attracted Nearly 160,000 Visits in Four Days

Setting highest annual visitation to date Offering Macao's largest free sales platform to empower local SMEs  Drawing 800,000 visits across seven editions MACAO, July 28, 2026 /PRNewswire/ -- The "2026 Sands Shopping Carnival," an annual signature shopping event in Macao, was held successfully fr...

2026-07-28 01:12 775

Everest Medicines Announces Participation in Upcoming Investor Conferences

SHANGHAI, July 27, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Fi...

2026-07-27 23:17 4285

Longsys to Unveil "Edge AI Storage Fusion" at FMS 2026, Showcasing In-Depth Innovation in Edge AI Storage

SAN JOSE, Calif., July 27, 2026 /PRNewswire/ -- FMS 2026 kicks off in California, USA, August 4–6, 2026. Longsys(301308.SZ) will attend under the theme "Edge AI Storage Fusion," showcasing its deep innovation in edge AI storage. Comprehensi...

2026-07-27 23:00 6030

Cyient Elevates Andrew Smith as COO to Drive Global Delivery Excellence & Accelerate Growth

HYDERABAD, India, July 27, 2026 /PRNewswire/ -- Cyient Limited, a global lifecycle engineering company, announced the elevation of Andrew Smith as Chief Operating Officer (COO), reinforcing the company's commitment to operational excellence, scalable growth, and superior customer outcomes. The ap...

2026-07-27 21:24 4901

Seegene Proposes Comprehensive Reproductive Tract Infection Testing Approach through the Global Million Clinical Study (GMCS)

* STAgora™ analysis of approximately 60,000 test results collected over 42 months showed that STI pathogens were detected in 82% of HPV-positive cases * Findings support the potential value of a comprehensive testing approach that provides both HPV and STI pathogen information * Seegene to v...

2026-07-27 21:00 8101

AsymBio Kicks Off Construction of Fengxian R&D Building to Establish a Full-Lifecycle, One-Stop Biologics Service Ecosystem

SHANGHAI, July 27, 2026 /PRNewswire/ -- AsymBio , a biologics-focused Contract Development and Manufacturing Organization (CDMO) and a subsidiary of Asymchem Group  (stock codes: 002821.SZ / 6821.HK), today announced that construction of its ne...

2026-07-27 21:00 4285

NYSE Content Update: KPMG Study Reveals How Well Employees Work with AI

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 27, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begin...

2026-07-27 20:57 7359

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships

TAIPEI, July 27, 2026 /PRNewswire/ -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company" or "Jyong Biotech"), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics,today reaffirmed its strategic focus on pursuing global li...

2026-07-27 20:20 5072

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

* Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. * Offers 5x greater sensitivity vs. in-class instruments with lower detection limits in smaller sample volum...

2026-07-27 20:10 5382

BASF Agricultural Solutions starts global registration of novel PPO herbicide Replexor™ Active

* Regulatory dossiers for Replexor Active submitted in Brazil and Australia; US and Argentina to follow in 2027 * Rounding out weed control spectrum, Replexor Active strengthens integrated PPO herbicide portfolio, helping growers maximize the value of their weed management programs * Start ...

2026-07-27 20:00 5106

Insilico Medicine Announces Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of ISM6331 in Mesothelioma and Advanced Solid Tumors

Presentation to feature first-in-human results for ISM6331, a novel, AI-designed pan-TEAD inhibitor targeting the Hippo pathway Global Phase 1 multicenter study evaluates safety, tolerability, and preliminary efficacy in patients with mesothelioma and other advanced solid tumors CAMBRIDGE, Mass...

2026-07-27 20:00 7928

HTCO Announces Ten-Year Extension of Singapore MSI-AIS Maritime Tax Exemption Through 2035

MSI-AIS Award Extended Through 2035, Providing Long-Term Tax Certainty and Enhancing Competitive Position in Global Shipping NEW YORK, July 27, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) ("HTCO" or the "Company"), a global maritime logistics company, today announced that ...

2026-07-27 20:00 4906

Ohmyhome Ltd Announces Pricing of $4 Million Registered Direct Offering

SINGAPORE, July 27, 2026 /PRNewswire/ -- Ohmyhome Ltd (NASDAQ: OMH) (the "Company"), a data- and technology-driven digital marketing company delivering multi-channel marketing and content solutions for advertisers, today announced that it has entered into securities purchase agreements with certa...

2026-07-27 20:00 9445

Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565

CHENGDU, China, July 27, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) today announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA)...

2026-07-27 19:40 5715

Sharon AI to Announce Second Quarter 2026 Results

NEW YORK, July 27, 2026 /PRNewswire/ -- Sharon AI Holdings Inc. (NASDAQ: SHAZ) and its subsidiaries ("Sharon AI"), a leading Australian Neocloud, will release its second quarter 2026 financial results after the market closes on Thursday, August 6, 2026, followed by a conference call and webcast t...

2026-07-27 19:10 7146

Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model

-ASC37 demonstrated statistically significant 88% greater relative body weight reduction compared to tirzepatide in the diet-induced obese (DIO) mouse model. -Both ASC37 once-monthly subcutaneous (SQ) formulation and oral formulation will be submitted to the U.S. Food and Drug Administration (FDA...

2026-07-27 18:42 6150
1 ... 86878889909192 ... 1653

Week's Top Stories